Dr Annarita Miccio told the ELRIG meeting in March 2026 that gene therapy for sickle cell disease and beta-thalassaemia has ...
Speaking at the ELRIG meeting at Hinxton Hall in March, Dr Seng H. Cheng set out how next-generation adeno-associated viral ...
Dr Terri Gaskell told the ELRIG meeting that Rinri Therapeutics has built Rincell-1, an off-the-shelf regenerative cell ...
The Bunsen-Kirchhoff Award for Analytical Spectroscopy 2026 was presented at analytica 2026 on 26 March, recognising ...
Preliminary genomic analysis has linked defects in natural killer cell pathways to earlier breast cancer diagnosis in women ...
Ikarovec has presented preclinical evidence for IKAR-001, a dual-pathway gene therapy designed to combine complement ...
SEM, a next-generation system designed to improve precision and efficiency in sample preparation for advanced microscopy ...
Since FDA approval of the use of recombinant insulin (the first biopharmaceutical) in 1982, adoption of biological ...
In industries where failure is not an option, average data is useless. Decisions worth millions require high confidence.
Parent advocate Mrs Dharmisha Stezaly speaking at ELRIG in March 2026 set out how early treatment with the gene therapy ...
PEAK International Group has launched a new brand identity at Analytica Munich 2026, bringing PEAK Scientific, Noblegen ...
A new science and technology hub in West London has confirmed its first tenant ahead of opening, as efforts grow to address ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results